Section Arrow
PEN.NYSE
- Penumbra
Quotes are at least 15-min delayed:2026/08/06 01:21 EDT
Regular Hours
Last
 323.21
-1.01 (-0.31%)
Day High 
323.8325 
Prev. Close
324.22 
1-M High
324.35 
Volume 
282.96K 
Bid
323.21
Ask
345
Day Low
322.23 
Open
323.36 
1-M Low
315.69 
Market Cap 
12.77B 
Currency 美元 
P/E 79.66 
%Yield -- 
10-SMA 320.1 
20-SMA 318.98 
50-SMA 318.94 
52-W High 362.41 
52-W Low 221.26 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
4.07/5.87
Enterprise Value
12.97B
Balance Sheet
Book Value Per Share
38.86
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
1.40B
Operating Revenue Per Share
25.26
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BJDXBluejay Diagnostics Inc.1.24+0.24+24.00%-- 
BSXBoston Scientific Corp47.74-1.35-2.75%20.57PE
AMIXAutonomix Medical Inc.12.1-7.4-37.95%-- 
ADGMAdagio Medical Holdings Inc.0.739-0.061-7.63%-- 
PACBPacific Biosciences of California1.3-0.14-9.72%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.